|
PPP1R15B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.29496454962464E-14 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.43027820090447E-13 |
| Normal-vs-Stage2 |
4.68292071786891E-13 |
| Normal-vs-Stage3 |
1.62991842245219E-12 |
| Normal-vs-Stage4 |
1.63236091310637E-12 |
| Stage1-vs-Stage2 |
6.905800E-01 |
| Stage1-vs-Stage3 |
7.393900E-02 |
| Stage1-vs-Stage4 |
7.419800E-02 |
| Stage2-vs-Stage3 |
3.170400E-01 |
| Stage2-vs-Stage4 |
2.963200E-01 |
| Stage3-vs-Stage4 |
9.535400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.03028696685215E-13 |
| Normal-vs-AfricanAmerican |
1.42529998914398E-09 |
| Normal-vs-Asian |
1.63979940737136E-12 |
| Caucasian-vs-AfricanAmerican |
5.034000E-01 |
| Caucasian-vs-Asian |
1.987770E-01 |
| AfricanAmerican-vs-Asian |
1.325440E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.63091762317435E-12 |
| Normal-vs-Female |
1.76580972066631E-12 |
| Male-vs-Female |
7.590400E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.35367281220533E-13 |
| Normal-vs-Age(41-60Yrs) |
3.71924713249427E-14 |
| Normal-vs-Age(61-80Yrs) |
2.26485497023532E-14 |
| Normal-vs-Age(81-100Yrs) |
4.822400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.815800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.543400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.894600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.952600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.832600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.600800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.50776999999769E-05 |
| Classical-VS-Follicular |
6.477000E-01 |
| Classical-VS-Other |
2.795800E-01 |
| Classical-VS-Normal |
2.7743363162358E-12 |
| Tall-VS-Follicular |
3.942100E-03 |
| Tall-VS-Other |
5.510600E-01 |
| Tall-VS-Normal |
1.62470037423645E-12 |
| Follicular-VS-Other |
4.446000E-01 |
| Follicular-VS-Normal |
3.08575387464316E-12 |
| Other-VS-Normal |
9.66510005362409E-09 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.65112368222253E-12 |
| Normal-vs-N1 |
1.62747593179802E-12 |
| N0-vs-N1 |
1.920790E-01 |
|
|
